An observational study in Ethnic Group, Young Adults and Prediabetes, sponsored by Meir Medical Center. Status unknown at 1 site in Israel. Open to participants aged 25 Years to 55 Years. Per ClinicalTrials.gov, last updated 2012-08-08.
Sponsored by Meir Medical Center · Observational
This study will evaluate the feasibility and efficacy of two interventions of lifestyle ( intensive and less intensive) to prevent diabetes in patients from Ethiopian origin, aged 25 to 55 years old with prediabetes living in Israel and insured by Clalit Health Services in the Central district, using resources existing in this Health Care system (HMO).
1,021 studies on the registry are indexed under Prediabetic State; 242 are open to participants now.
This study's planned enrollment of 200 is close to the median of 207 across 131 observational studies indexed under Prediabetic State.
Browse Prediabetic State studies →Meir Medical Center is the lead sponsor of 400 studies on the registry; 25 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients aged 25-55 from Ethiopian origin leaving in Israel with pre diabetes
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: intensive lifestyle counseling
Behavioral: intensive lifestyle counseling
Intensive lifestyle counseling will include a bi annual visit of the primary physician and nurse, a group intervention about use of medical resources, healthy lifestyle a one to one intervention with a dietician about diet and a one to one intervention with a physiotherapist about exercise
occurence of diabetes
Patients included in the study will have a one year lifestyle intervention ( two arms: intensive, less intensive) and will be followed for two years for the occurence of diabetes
Time frame: two years period
change in Body Mass index and Physical activity
Time frame: two years
This study is status unknown, as verified in Aug 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.